25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HCWB (HCW Biologics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze HCW Biologics Inc together

I guess you are interested in HCW Biologics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – HCW Biologics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – HCW Biologics Inc’s Price Targets

I'm going to help you getting a better view of HCW Biologics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about HCW Biologics Inc

I send you an email if I find something interesting about HCW Biologics Inc.

1. Quick Overview

1.1. Quick analysis of HCW Biologics Inc (30 sec.)










1.2. What can you expect buying and holding a share of HCW Biologics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.5%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$0.12
How sure are you?
26.3%

+ What do you gain per year?

Total Gains per Share
$0.14
Return On Investment
3.4%

For what price can you sell your share?

Current Price per Share
$4.15
Expected price per share
$2.77 - $15.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of HCW Biologics Inc (5 min.)




Live pricePrice per Share (EOD)
$4.15
Intrinsic Value Per Share
$-75.66 - $-90.69
Total Value Per Share
$-75.68 - $-90.71

2.2. Growth of HCW Biologics Inc (5 min.)




Is HCW Biologics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$51.9k$9.9m-$16.2m-256.9%

How much money is HCW Biologics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.3m-$9.5m$4.2m78.0%
Net Profit Margin-57,398.5%-1,129.4%--

How much money comes from the company's main activities?

2.3. Financial Health of HCW Biologics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#723 / 853

Most Revenue
#553 / 853

Most Profit
#423 / 853

Most Efficient
#836 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of HCW Biologics Inc?

Welcome investor! HCW Biologics Inc's management wants to use your money to grow the business. In return you get a share of HCW Biologics Inc.

First you should know what it really means to hold a share of HCW Biologics Inc. And how you can make/lose money.

Speculation

The Price per Share of HCW Biologics Inc is $4.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HCW Biologics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HCW Biologics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HCW Biologics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-5.62-135.3%-1.46-35.3%-0.26-6.3%-0.62-14.9%-0.42-10.1%-0.42-10.1%
Usd Book Value Change Per Share0.174.0%0.040.9%-0.24-5.8%-0.11-2.6%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%0.010.1%
Usd Total Gains Per Share0.174.0%0.040.9%-0.24-5.8%-0.11-2.6%0.000.1%0.000.1%
Usd Price Per Share3.97-1.31-1.38-1.54-1.52-1.52-
Price to Earnings Ratio-0.18--1.05--1.77--2.22--2.91--2.91-
Price-to-Total Gains Ratio23.67-1.66--8.21--7.64-1,099.56-1,099.56-
Price to Book Ratio-164.15--42.56-2.43--12.71--7.67--7.67-
Price-to-Total Gains Ratio23.67-1.66--8.21--7.64-1,099.56-1,099.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.15
Number of shares240
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.040.00
Usd Total Gains Per Share0.040.00
Gains per Quarter (240 shares)8.540.94
Gains per Year (240 shares)34.183.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1034245-1-6
20685810-2-2
301039215-42
4013712620-56
5017116025-610
6020519430-714
7023922835-918
8027326240-1022
9030829645-1126
10034233050-1230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.018.00.05.3%1.018.00.05.3%1.018.00.05.3%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%4.015.00.021.1%4.015.00.021.1%4.015.00.021.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.017.010.5%2.00.017.010.5%2.00.017.010.5%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%5.014.00.026.3%5.014.00.026.3%5.014.00.026.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of HCW Biologics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1670.036+370%-0.241+244%-0.109+165%-0.001+101%-0.001+101%
Book Value Per Share---0.024-0.163+577%0.277-109%0.366-107%0.617-104%0.617-104%
Current Ratio--0.1080.110-2%0.964-89%3.277-97%8.093-99%8.093-99%
Debt To Asset Ratio--1.0021.232-19%0.701+43%0.719+39%0.487+105%0.487+105%
Debt To Equity Ratio----0%1.023-100%0.439-100%0.319-100%0.319-100%
Dividend Per Share----0%-0%-0%0.005-100%0.005-100%
Enterprise Value---17991512.350-17320226.685-4%34215708.055-153%34204349.324-153%55417148.051-132%55417148.051-132%
Eps---5.615-1.464-74%-0.260-95%-0.618-89%-0.418-93%-0.418-93%
Ev To Ebitda Ratio--1.2981.647-21%-1.743+234%-1.670+229%-4.035+411%-4.035+411%
Ev To Sales Ratio---686.699-437.090-36%8.216-8458%-103.946-85%-84.020-88%-84.020-88%
Free Cash Flow Per Share---1.526-0.440-71%-0.153-90%-0.270-82%-0.203-87%-0.203-87%
Free Cash Flow To Equity Per Share--0.6190.157+293%-0.112+118%-0.043+107%0.039+1484%0.039+1484%
Gross Profit Margin--1.0001.016-2%1.0040%1.007-1%1.0040%1.0040%
Intrinsic Value_10Y_max---90.689----------
Intrinsic Value_10Y_min---75.660----------
Intrinsic Value_1Y_max---2.243----------
Intrinsic Value_1Y_min---2.199----------
Intrinsic Value_3Y_max---11.955----------
Intrinsic Value_3Y_min---11.308----------
Intrinsic Value_5Y_max---27.957----------
Intrinsic Value_5Y_min---25.500----------
Market Cap8929181.500+4%8531133.65014710410.065-42%50501229.305-83%44981304.324-81%46272880.569-82%46272880.569-82%
Net Profit Margin---1844.508-573.985-69%-11.294-99%-205.879-89%-130.447-93%-130.447-93%
Operating Margin----121.8460%-9.1850%-55.4230%-35.4190%-35.4190%
Operating Ratio--529.067327.786+61%12.501+4132%125.569+321%79.877+562%79.877+562%
Pb Ratio-171.808-5%-164.149-42.556-74%2.427-6864%-12.707-92%-7.669-95%-7.669-95%
Pe Ratio-0.185-5%-0.177-1.050+495%-1.767+901%-2.224+1160%-2.912+1550%-2.912+1550%
Price Per Share4.150+4%3.9651.308+203%1.381+187%1.544+157%1.525+160%1.525+160%
Price To Free Cash Flow Ratio-0.680-5%-0.650-1.184+82%-2.455+278%-2.135+229%-3.035+367%-3.035+367%
Price To Total Gains Ratio24.777+4%23.6721.663+1323%-8.214+135%-7.641+132%1099.556-98%1099.556-98%
Quick Ratio--0.0920.0920%0.712-87%3.646-97%10.358-99%10.358-99%
Return On Assets---0.418-0.190-55%-0.332-21%-0.208-50%-0.160-62%-0.160-62%
Return On Equity----0%-0.4640%-0.1990%-0.1610%-0.1610%
Total Gains Per Share--0.1670.036+370%-0.241+244%-0.109+165%0.004+4161%0.004+4161%
Usd Book Value---51972.000-6338454.000+12096%9942370.500-101%12966997.417-100%20590256.368-100%20590256.368-100%
Usd Book Value Change Per Share--0.1670.036+370%-0.241+244%-0.109+165%-0.001+101%-0.001+101%
Usd Book Value Per Share---0.024-0.163+577%0.277-109%0.366-107%0.617-104%0.617-104%
Usd Dividend Per Share----0%-0%-0%0.005-100%0.005-100%
Usd Enterprise Value---17991512.350-17320226.685-4%34215708.055-153%34204349.324-153%55417148.051-132%55417148.051-132%
Usd Eps---5.615-1.464-74%-0.260-95%-0.618-89%-0.418-93%-0.418-93%
Usd Free Cash Flow---3282303.000-3176996.500-3%-5601745.000+71%-5528725.333+68%-4487352.158+37%-4487352.158+37%
Usd Free Cash Flow Per Share---1.526-0.440-71%-0.153-90%-0.270-82%-0.203-87%-0.203-87%
Usd Free Cash Flow To Equity Per Share--0.6190.157+293%-0.112+118%-0.043+107%0.039+1484%0.039+1484%
Usd Market Cap8929181.500+4%8531133.65014710410.065-42%50501229.305-83%44981304.324-81%46272880.569-82%46272880.569-82%
Usd Price Per Share4.150+4%3.9651.308+203%1.381+187%1.544+157%1.525+160%1.525+160%
Usd Profit---12081529.000-5388491.250-55%-9591856.000-21%-6530030.917-46%-4995035.947-59%-4995035.947-59%
Usd Revenue--6550.000208210.500-97%980667.500-99%714228.917-99%854844.316-99%854844.316-99%
Usd Total Gains Per Share--0.1670.036+370%-0.241+244%-0.109+165%0.004+4161%0.004+4161%
 EOD+7 -1MRQTTM+13 -22YOY+12 -243Y+12 -245Y+11 -2710Y+11 -27

3.3 Fundamental Score

Let's check the fundamental score of HCW Biologics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.185
Price to Book Ratio (EOD)Between0-1-171.808
Net Profit Margin (MRQ)Greater than0-1,844.508
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.092
Current Ratio (MRQ)Greater than10.108
Debt to Asset Ratio (MRQ)Less than11.002
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.418
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of HCW Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.260
Ma 20Greater thanMa 504.514
Ma 50Greater thanMa 1004.430
Ma 100Greater thanMa 2005.465
OpenGreater thanClose4.830
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Fundamental data was last updated by Penke on 2025-09-04 01:01:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ HCW Biologics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -184,450.8%Β means thatΒ $-1,844.51 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HCW Biologics Inc:

  • The MRQ is -184,450.8%. The company is making a huge loss. -2
  • The TTM is -57,398.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-184,450.8%TTM-57,398.5%-127,052.3%
TTM-57,398.5%YOY-1,129.4%-56,269.1%
TTM-57,398.5%5Y-13,044.7%-44,353.8%
5Y-13,044.7%10Y-13,044.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-184,450.8%-85.5%-184,365.3%
TTM-57,398.5%-171.0%-57,227.5%
YOY-1,129.4%-210.0%-919.4%
3Y-20,587.9%-289.9%-20,298.0%
5Y-13,044.7%-381.1%-12,663.6%
10Y-13,044.7%-520.3%-12,524.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ HCW Biologics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • -41.8% Return on Assets means thatΒ HCW Biologics Inc generatedΒ $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HCW Biologics Inc:

  • The MRQ is -41.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.8%TTM-19.0%-22.8%
TTM-19.0%YOY-33.2%+14.2%
TTM-19.0%5Y-16.0%-3.0%
5Y-16.0%10Y-16.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.8%-11.9%-29.9%
TTM-19.0%-11.9%-7.1%
YOY-33.2%-11.2%-22.0%
3Y-20.8%-12.0%-8.8%
5Y-16.0%-11.7%-4.3%
10Y-16.0%-13.8%-2.2%
4.3.1.3. Return on Equity

Shows how efficient HCW Biologics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means HCW Biologics Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HCW Biologics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-46.4%+46.4%
TTM-5Y-16.1%+16.1%
5Y-16.1%10Y-16.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.2%+15.2%
YOY-46.4%-15.3%-31.1%
3Y-19.9%-16.9%-3.0%
5Y-16.1%-17.5%+1.4%
10Y-16.1%-19.6%+3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of HCW Biologics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient HCW Biologics Inc is operatingΒ .

  • Measures how much profit HCW Biologics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HCW Biologics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-12,184.6%+12,184.6%
TTM-12,184.6%YOY-918.5%-11,266.2%
TTM-12,184.6%5Y-3,541.9%-8,642.7%
5Y-3,541.9%10Y-3,541.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM-12,184.6%-280.2%-11,904.4%
YOY-918.5%-268.7%-649.8%
3Y-5,542.3%-281.5%-5,260.8%
5Y-3,541.9%-350.8%-3,191.1%
10Y-3,541.9%-530.7%-3,011.2%
4.3.2.2. Operating Ratio

Measures how efficient HCW Biologics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 529.07 means that the operating costs are $529.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of HCW Biologics Inc:

  • The MRQ is 529.067. The company is inefficient in keeping operating costs low. -1
  • The TTM is 327.786. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ529.067TTM327.786+201.281
TTM327.786YOY12.501+315.285
TTM327.7865Y79.877+247.909
5Y79.87710Y79.8770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ529.0671.952+527.115
TTM327.7862.974+324.812
YOY12.5013.047+9.454
3Y125.5693.835+121.734
5Y79.8774.924+74.953
10Y79.8776.864+73.013
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of HCW Biologics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if HCW Biologics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.11Β means the company has $0.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.108. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.110. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.108TTM0.110-0.002
TTM0.110YOY0.964-0.854
TTM0.1105Y8.093-7.983
5Y8.09310Y8.0930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1083.480-3.372
TTM0.1103.790-3.680
YOY0.9644.104-3.140
3Y3.2774.609-1.332
5Y8.0935.764+2.329
10Y8.0936.154+1.939
4.4.3.2. Quick Ratio

Measures if HCW Biologics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.09Β means the company can pay off $0.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.092. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.092. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.092TTM0.0920.000
TTM0.092YOY0.712-0.620
TTM0.0925Y10.358-10.266
5Y10.35810Y10.3580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0922.938-2.846
TTM0.0923.291-3.199
YOY0.7123.928-3.216
3Y3.6464.393-0.747
5Y10.3585.837+4.521
10Y10.3586.549+3.809
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of HCW Biologics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of HCW Biologics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ HCW Biologics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.00Β means that HCW Biologics Inc assets areΒ financed with 100.2% credit (debt) and the remaining percentage (100% - 100.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of HCW Biologics Inc:

  • The MRQ is 1.002. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.232. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.002TTM1.232-0.230
TTM1.232YOY0.701+0.530
TTM1.2325Y0.487+0.744
5Y0.48710Y0.4870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0020.339+0.663
TTM1.2320.359+0.873
YOY0.7010.334+0.367
3Y0.7190.341+0.378
5Y0.4870.349+0.138
10Y0.4870.379+0.108
4.5.4.2. Debt to Equity Ratio

Measures ifΒ HCW Biologics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.023-1.023
TTM-5Y0.319-0.319
5Y0.31910Y0.3190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.391-0.391
TTM-0.436-0.436
YOY1.0230.436+0.587
3Y0.4390.461-0.022
5Y0.3190.461-0.142
10Y0.3190.514-0.195
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings HCW Biologics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ HCW Biologics Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.18 means the investor is paying $-0.18Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HCW Biologics Inc:

  • The EOD is -0.185. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.177. Based on the earnings, the company is expensive. -2
  • The TTM is -1.050. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.185MRQ-0.177-0.008
MRQ-0.177TTM-1.050+0.874
TTM-1.050YOY-1.767+0.717
TTM-1.0505Y-2.912+1.862
5Y-2.91210Y-2.9120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.185-2.539+2.354
MRQ-0.177-2.361+2.184
TTM-1.050-2.657+1.607
YOY-1.767-3.749+1.982
3Y-2.224-3.883+1.659
5Y-2.912-6.353+3.441
10Y-2.912-7.102+4.190
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HCW Biologics Inc:

  • The EOD is -0.680. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.650. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.184. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.680MRQ-0.650-0.030
MRQ-0.650TTM-1.184+0.534
TTM-1.184YOY-2.455+1.271
TTM-1.1845Y-3.035+1.852
5Y-3.03510Y-3.0350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.680-3.411+2.731
MRQ-0.650-2.951+2.301
TTM-1.184-3.614+2.430
YOY-2.455-4.421+1.966
3Y-2.135-5.258+3.123
5Y-3.035-8.587+5.552
10Y-3.035-9.639+6.604
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ HCW Biologics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -164.15 means the investor is paying $-164.15Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of HCW Biologics Inc:

  • The EOD is -171.808. Based on the equity, the company is expensive. -2
  • The MRQ is -164.149. Based on the equity, the company is expensive. -2
  • The TTM is -42.556. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-171.808MRQ-164.149-7.659
MRQ-164.149TTM-42.556-121.593
TTM-42.556YOY2.427-44.982
TTM-42.5565Y-7.669-34.887
5Y-7.66910Y-7.6690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-171.8082.206-174.014
MRQ-164.1492.027-166.176
TTM-42.5562.194-44.750
YOY2.4272.425+0.002
3Y-12.7072.571-15.278
5Y-7.6693.805-11.474
10Y-7.6694.462-12.131
4.6.2. Total Gains per Share

2.4. Latest News of HCW Biologics Inc

Does HCW Biologics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from HCW Biologics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-12
21:00
Which stocks are experiencing notable movement on Friday?Read
2025-09-12
18:30
Keep an eye on the top gainers and losers in Friday's session.Read
2025-08-19
21:17
HCW Biologics GAAP EPS of -$16.16, revenue of $180.4MRead
2025-08-19
20:02
HCW Biologics GAAP EPS of -$16.16Read
2025-08-18
20:44
HCW Biologics Reports Second Quarter 2025Β Business Highlights and Financial ResultsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of HCW Biologics Inc.

4.8.1. Institutions holding HCW Biologics Inc

Institutions are holding 1.002% of the shares of HCW Biologics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Geode Capital Management, LLC0.27602369675501030.2324
2025-03-31J.W. COLE ADVISORS, INC.0.06220.000553402534020
2025-03-31BlackRock Inc0.0491042182-807-1.8772
2025-03-31AE Wealth Management LLC0.03490.00013000000
2025-03-31State Street Corp0.02502144600
2025-03-31JustInvest LLC0.01890.000116264162640
2025-03-31Northern Trust Corp0.011901020500
2025-03-31Advisor Group Holdings, Inc.0.00120101010100
2025-06-30Tower Research Capital LLC0.0116025024924900
2025-03-31Bank of America Corp0.000202106443.8356
2025-03-31HighTower Advisors, LLC000-180810-100
2025-03-31Bridgeway Capital Management, LLC000-34700-100
2025-06-30Cresset Asset Management, LLC000-3300-100
2025-06-30Citigroup Inc000-351-100
2025-03-31Renaissance Technologies Corp000-15000-100
2025-06-30Vanguard Group Inc000-6079-100
2025-03-31Armistice Capital, LLC000-2023664-100
2025-06-30Honkamp Krueger Financial Services Inc000-6989-100
2025-03-31Two Sigma Investments LLC000-12082-100
2025-03-31Virtu Financial LLC000-15623-100
Total 0.4910.0007411936-2173406-527.6%

4.9.2. Funds holding HCW Biologics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.194604177-1903-31.2993
2025-06-30Fidelity Extended Market Index0.16160346800
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00250.0001215921590
2025-06-30Spartan Extended Market Index Pool F0.08710.000118701509418.0055
2025-03-31SSgA U.S. Total Market Index Strategy0.001501257272.1951
2025-06-30Fidelity Series Total Market Index0.04410946-628-39.8983
2025-06-30Fidelity Total Market Index0.0338072600
2025-06-30Fidelity Nasdaq Composite Index0.0192041200
2025-06-30Spartan Total Market Index Pool G0.014030100
2025-06-30NT Ext Equity Mkt Idx Fd - L0.0106022820.885
2025-06-30Northern Trust Extended Eq Market Idx0.010602282223700
2025-06-30ZWJ Balanced0.0037079773850
2025-07-31State St US Extended Mkt Indx NL Cl C0.003507500
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0030641018.5185
2025-06-30Northern Trust Wilshire 50000.0014029282800
2025-07-31State St US Ttl Mkt Indx NL Cl A0.001102300
2025-06-30Fidelity U.S. Equity Index Ins Trust0.00020400
Total 0.59250.000216046+1503+9.4%

5.3. Insider Transactions

Insiders are holding 27.303% of the shares of HCW Biologics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-05-08Gary M WinerBUY230826
2025-05-08Lee FlowersBUY96226
2025-05-08Rebecca ByamBUY846226
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets28,910
Total Liabilities28,962
Total Stockholder Equity-52
 As reported
Total Liabilities 28,962
Total Stockholder Equity+ -52
Total Assets = 28,910

Assets

Total Assets28,910
Total Current Assets2,897
Long-term Assets26,013
Total Current Assets
Cash And Cash Equivalents 2,439
Net Receivables 22
Other Current Assets 437
Total Current Assets  (as reported)2,897
Total Current Assets  (calculated)2,897
+/-0
Long-term Assets
Property Plant Equipment 22,636
Long Term Investments 3,348
Long-term Assets Other 28
Long-term Assets  (as reported)26,013
Long-term Assets  (calculated)26,013
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities26,846
Long-term Liabilities2,116
Total Stockholder Equity-52
Total Current Liabilities
Short-term Debt 6,421
Short Long Term Debt 6,421
Accounts payable 19,354
Other Current Liabilities 1,070
Total Current Liabilities  (as reported)26,846
Total Current Liabilities  (calculated)33,267
+/- 6,421
Long-term Liabilities
Long term Debt 367
Long-term Liabilities Other 1,748
Long-term Liabilities  (as reported)2,116
Long-term Liabilities  (calculated)2,116
+/-0
Total Stockholder Equity
Common Stock0
Retained Earnings -104,681
Other Stockholders Equity 104,629
Total Stockholder Equity (as reported)-52
Total Stockholder Equity (calculated)-52
+/-0
Other
Capital Stock0
Cash and Short Term Investments 2,439
Common Stock Shares Outstanding 1,780
Liabilities and Stockholders Equity 28,910
Net Debt 3,982
Net Invested Capital 6,736
Net Working Capital -23,949
Short Long Term Debt Total 6,421



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
15,398
12,928
13,033
56,406
53,515
50,956
47,408
51,353
46,809
43,535
39,483
35,616
28,514
30,428
26,820
26,556
30,237
26,285
28,910
28,91026,28530,23726,55626,82030,42828,51435,61639,48343,53546,80951,35347,40850,95653,51556,40613,03312,92815,398000
   > Total Current Assets 
7,356
0
0
12,149
9,799
10,046
43,559
40,480
37,906
34,628
28,708
34,071
29,940
19,799
13,848
6,404
6,209
2,386
2,094
5,698
1,895
2,897
2,8971,8955,6982,0942,3866,2096,40413,84819,79929,94034,07128,70834,62837,90640,48043,55910,0469,79912,149007,356
       Cash And Cash Equivalents 
-7,356
0
0
8,456
6,856
5,051
15,125
11,731
18,117
15,420
26,224
22,326
18,390
7,449
11,221
3,595
4,084
1,161
998
4,675
1,108
2,439
2,4391,1084,6759981,1614,0843,59511,2217,44918,39022,32626,22415,42018,11711,73115,1255,0516,8568,45600-7,356
       Short-term Investments 
14,712
0
0
0
0
1,600
24,990
24,984
16,969
16,994
0
9,736
9,848
9,959
0
0
0
0
0
0
0
0
000000009,9599,8489,736016,99416,96924,98424,9901,600000014,712
       Net Receivables 
0
0
0
2,500
1,300
50
70
133
553
347
356
418
253
707
710
1,536
1,154
655
652
582
87
22
22875826526551,1541,53671070725341835634755313370501,3002,500000
       Other Current Assets 
0
0
0
1,193
1,643
4,945
3,374
3,633
2,266
1,868
2,128
1,591
317
1,684
1,917
231
971
570
444
442
700
437
4377004424445709712311,9171,6843171,5912,1281,8682,2663,6333,3744,9451,6431,193000
   > Long-term Assets 
-7,356
0
0
3,249
3,129
2,987
12,847
13,034
13,050
12,780
22,645
12,738
13,594
19,684
21,768
22,109
24,219
24,434
24,462
24,538
24,391
26,013
26,01324,39124,53824,46224,43424,21922,10921,76819,68413,59412,73822,64512,78013,05013,03412,8472,9873,1293,24900-7,356
       Property Plant Equipment 
0
0
0
1,615
1,529
1,387
1,269
1,119
1,012
914
10,958
10,805
11,741
12,623
14,781
20,453
22,591
22,806
22,834
22,910
22,762
22,636
22,63622,76222,91022,83422,80622,59120,45314,78112,62311,74110,80510,9589141,0121,1191,2691,3871,5291,615000
       Long Term Investments 
0
0
0
1,600
1,600
1,600
11,578
11,522
11,351
11,303
11,269
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
3,348
3,3481,6001,6001,6001,6001,6001,6001,6001,6001,6001,60011,26911,30311,35111,52211,5781,6001,6001,600000
       Long-term Assets Other 
-7,356
0
0
34
0
1,600
11,578
393
686
564
419
334
253
5,461
5,388
57
28
28
28
28
28
28
282828282828575,3885,46125333441956468639311,5781,60003400-7,356
> Total Liabilities 
0
0
0
1,001
1,347
4,169
2,395
2,322
1,557
1,243
8,798
9,381
10,916
10,898
11,749
15,052
21,687
33,120
36,526
37,007
34,847
28,962
28,96234,84737,00736,52633,12021,68715,05211,74910,89810,9169,3818,7981,2431,5572,3222,3954,1691,3471,001000
   > Total Current Liabilities 
0
0
0
1,001
1,347
4,169
2,395
2,322
1,417
1,145
2,293
2,956
4,522
4,538
5,417
8,748
13,413
23,219
30,063
29,629
27,142
26,846
26,84627,14229,62930,06323,21913,4138,7485,4174,5384,5222,9562,2931,1451,4172,3222,3954,1691,3471,001000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
6,448
6,410
146
97
118
0
29
124
6,341
6,315
6,234
6,421
6,4216,2346,3156,341124290118971466,4106,4480000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
122
124
6,341
6,315
6,234
6,421
6,4216,2346,3156,3411241220000000000000000
       Accounts payable 
0
0
0
155
323
997
637
224
743
296
1,410
1,226
1,165
2,116
3,154
6,167
10,493
16,877
22,666
22,332
19,734
19,354
19,35419,73422,33222,66616,87710,4936,1673,1542,1161,1651,2261,410296743224637997323155000
       Other Current Liabilities 
0
0
0
846
1,023
3,173
1,757
2,098
674
848
883
1,730
3,357
2,422
2,263
0
2,919
6,218
1,057
982
1,174
1,070
1,0701,1749821,0576,2182,91902,2632,4223,3571,7308838486742,0981,7573,1731,023846000
   > Long-term Liabilities 
0
0
0
0
0
8,864
0
224
140
98
6,505
6,424
6,394
6,360
6,333
6,304
8,274
9,901
6,463
7,378
7,705
2,116
2,1167,7057,3786,4639,9018,2746,3046,3336,3606,3946,4246,5059814022408,86400000
       Other Liabilities 
0
0
0
0
0
0
0
0
140
98
57
0
0
0
0
0
0
0
0
0
0
0
00000000000579814000000000
> Total Stockholder Equity
9,000
0
0
14,397
11,581
8,864
54,011
51,193
49,399
46,165
42,555
37,429
32,619
28,586
23,867
13,462
8,741
-6,300
-9,970
-6,770
-8,562
-52
-52-8,562-6,770-9,970-6,3008,74113,46223,86728,58632,61937,42942,55546,16549,39951,19354,0118,86411,58114,397009,000
   Common Stock
0
0
0
0
0
0
4
4
4
4
4
4
4
4
4
0
4
4
4
4
4
0
0444440444444444000000
   Retained Earnings -104,681-102,753-100,556-97,183-93,281-78,000-70,532-59,852-54,913-50,609-45,538-40,119-36,205-32,695-30,637-27,464-23,240-20,026-16,719000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
82,367
82,671
82,963
83,224
0
0
0
0
0
0
0
0
0
00000000083,22482,96382,67182,367000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
23,240
81,472
81,827
82,090
82,367
82,671
82,963
83,224
83,495
83,715
0
86,737
86,977
87,209
93,782
94,186
104,629
104,62994,18693,78287,20986,97786,737083,71583,49583,22482,96382,67182,36782,09081,82781,47223,24000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,567
Cost of Revenue-1,607
Gross Profit959959
 
Operating Income (+$)
Gross Profit959
Operating Expense-28,832
Operating Income-29,480-27,872
 
Operating Expense (+$)
Research Development5,999
Selling General Administrative6,840
Selling And Marketing Expenses805
Operating Expense28,83213,643
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,158
Other Finance Cost-0
Net Interest Income-1,158
 
Pretax Income (+$)
Operating Income-29,480
Net Interest Income-1,158
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,024-28,936
EBIT - interestExpense = -30,024
-30,024
-28,865
Interest Expense1,158
Earnings Before Interest and Taxes (EBIT)-28,865-28,865
Earnings Before Interest and Taxes (EBITDA)-27,681
 
After tax Income (+$)
Income Before Tax-30,024
Tax Provision-0
Net Income From Continuing Ops-30,024-30,024
Net Income-30,024
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,836
Total Other Income/Expenses Net-5441,158
 

Technical Analysis of HCW Biologics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HCW Biologics Inc. The general trend of HCW Biologics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HCW Biologics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. HCW Biologics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HCW Biologics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.35 < 13.21 < 15.60.

The bearish price targets are: 2.77.

Know someone who trades $HCWB? Share this with them.πŸ‘‡

HCW Biologics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HCW Biologics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HCW Biologics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HCW Biologics Inc. The current macd is -0.05717866.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HCW Biologics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for HCW Biologics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the HCW Biologics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
HCW Biologics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHCW Biologics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HCW Biologics Inc. The current adx is 23.61.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HCW Biologics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
HCW Biologics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HCW Biologics Inc. The current sar is 6.45944302.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
HCW Biologics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HCW Biologics Inc. The current rsi is 47.26. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
HCW Biologics Inc Daily Relative Strength Index (RSI) ChartHCW Biologics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HCW Biologics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HCW Biologics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
HCW Biologics Inc Daily Stochastic Oscillator ChartHCW Biologics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HCW Biologics Inc. The current cci is -15.47811359.

HCW Biologics Inc Daily Commodity Channel Index (CCI) ChartHCW Biologics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HCW Biologics Inc. The current cmo is -6.63668894.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
HCW Biologics Inc Daily Chande Momentum Oscillator (CMO) ChartHCW Biologics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HCW Biologics Inc. The current willr is -73.60703812.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that HCW Biologics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
HCW Biologics Inc Daily Williams %R ChartHCW Biologics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of HCW Biologics Inc.

HCW Biologics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HCW Biologics Inc. The current atr is 0.74972917.

HCW Biologics Inc Daily Average True Range (ATR) ChartHCW Biologics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HCW Biologics Inc. The current obv is 160,708,048.

HCW Biologics Inc Daily On-Balance Volume (OBV) ChartHCW Biologics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HCW Biologics Inc. The current mfi is 83.77.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
HCW Biologics Inc Daily Money Flow Index (MFI) ChartHCW Biologics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HCW Biologics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-08-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

HCW Biologics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HCW Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.260
Ma 20Greater thanMa 504.514
Ma 50Greater thanMa 1004.430
Ma 100Greater thanMa 2005.465
OpenGreater thanClose4.830
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of HCW Biologics Inc with someone you think should read this too:
  • Are you bullish or bearish on HCW Biologics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HCW Biologics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HCW Biologics Inc

I send you an email if I find something interesting about HCW Biologics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about HCW Biologics Inc.

Receive notifications about HCW Biologics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.